Following ELRIGs Drug Discovery Conference, News Medical took part in an insightful discussion with Dr. Andrew Buchanan, a renowned figure in the realm of biopharmaceutical research. Dr. Buchanan’s career spans 22 years, notably at Cambridge Antibody Technology, MedImmune, and AstraZeneca, where he has significantly contributed to the development of 18 antibody-based drugs, including three successful … Read more
Researchers at Nagoya University in Japan created and improved artificial intelligence (AI) designs to synthesize a candidate compound for a new gastric acid inhibitor with a better binding affinity than existing drugs. Their findings, published in Communications Biology, suggest a new way to work in tandem with AI to develop pharmaceuticals. Stomach acid is a … Read more
Illustration by Lynne Carty/Barron’s staff; Dreamstime (4) Medicine is making big gains in the battle against cancer, enlisting the body’s own immune system to control or eliminate previously deadly tumors with a host… Source link credite
Are You Sure You Have Cancer? – WSJ The Wall Street Journal What a Coincidence: The Day I Found Out I Had Cancer Curetoday.com View Full Coverage on Google News Source link
Researchers at the Francis Crick Institute and UCL Queen Square Institute of Neurology, working with technology company Faculty AI, have shown that machine learning can accurately predict subtypes of Parkinson’s disease using images of patient-derived stem cells. Their work, published today in Nature Machine Intelligence, has shown that computer models can accurately classify four subtypes … Read more
The $76 Billion Diet Industry Asks: What to Do About Ozempic? The Wall Street Journal Source link